Brief: Kent Lake urges Quanterix to address questions regarding Akoya deal
17/03/2025 20:28
March 17 (Reuters) - Quanterix Corp QTRX.O: KENT LAKE URGES QUANTERIX MANAGEMENT TO ADDRESS KEY QUESTIONS REGARDING ITS PROPOSED TRANSACTION WITH AKOYA BIOSCIENCES DURING TODAY’S EARNINGS CALL KENT LAKE PR: BELIEVES PROPOSED TRANSACTION WITH AKOYA SIGNIFICANTLY UNDERVALUES QUANTERIX KENT LAKE: ENCOURAGES QUANTERIX SHAREHOLDERS TO VOTE AGAINST PROPOSED TRANSACTION WITH AKOYA Source text: ID:nBw1QHxXRa Further company coverage: QTRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quanterix
See all newsBrief: Alzpath And Quanterix Expand Strategic Licensing Agreement To Advance Next Generation Alzheimer's Disease Biomarker Research
Quanterix Corporation reports results for the quarter ended June 30 - Earnings Summary
Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Quanterix Corporation expected to post a loss of 46 cents a share - Earnings Preview
Quanterix Corp expected to post a loss of 46 cents a share - Earnings Preview